Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Needle-free immunization using a solid-in-oil nanodispersion enhanced by a skin-permeable oligoarginine peptide.

Kitaoka M, Imamura K, Hirakawa Y, Tahara Y, Kamiya N, Goto M.

Int J Pharm. 2013 Oct 24. pii: S0378-5173(13)00889-2. doi: 10.1016/j.ijpharm.2013.10.006. [Epub ahead of print]

PMID:
24513551
2.

Needle-free immunization using a solid-in-oil nanodispersion enhanced by a skin-permeable oligoarginine peptide.

Kitaoka M, Imamura K, Hirakawa Y, Tahara Y, Kamiya N, Goto M.

Int J Pharm. 2013 Dec 31;458(2):334-9.

PMID:
24409521
3.

Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.

Kitaoka M, Naritomi A, Hirakawa Y, Kamiya N, Goto M.

Pharm Res. 2015 Apr;32(4):1486-92. doi: 10.1007/s11095-014-1554-5. Epub 2014 Nov 1.

PMID:
25361868
4.

Transcutaneous immunization by a solid-in-oil nanodispersion.

Tahara Y, Namatsu K, Kamiya N, Hagimori M, Kamiya S, Arakawa M, Goto M.

Chem Commun (Camb). 2010 Dec 28;46(48):9200-2. doi: 10.1039/c0cc03600e. Epub 2010 Oct 28.

PMID:
21031190
5.

Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.

Mittal A, Raber AS, Schaefer UF, Weissmann S, Ebensen T, Schulze K, Guzmán CA, Lehr CM, Hansen S.

Vaccine. 2013 Jul 25;31(34):3442-51. doi: 10.1016/j.vaccine.2012.12.048. Epub 2013 Jan 2.

PMID:
23290836
6.

A solid-in-oil nanodispersion for transcutaneous protein delivery.

Tahara Y, Honda S, Kamiya N, Piao H, Hirata A, Hayakawa E, Fujii T, Goto M.

J Control Release. 2008 Oct 6;131(1):14-8. doi: 10.1016/j.jconrel.2008.07.015. Epub 2008 Jul 17.

PMID:
18687370
7.

Solid-in-oil nanodispersions for transdermal drug delivery systems.

Kitaoka M, Wakabayashi R, Kamiya N, Goto M.

Biotechnol J. 2016 Nov;11(11):1375-1385. doi: 10.1002/biot.201600081. Epub 2016 Aug 16. Review.

8.

Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.

Shahiwala A, Amiji MM.

J Drug Target. 2008 May;16(4):302-10. doi: 10.1080/10611860801900082 .

PMID:
18446609
9.

Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.

Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE.

Pharm Res. 2002 Jan;19(1):63-70.

PMID:
11837701
10.

Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles.

Bernardi DS, Bitencourt C, da Silveira DS, da Cruz EL, Pereira-da-Silva MA, Faccioli LH, Lopez RF.

Nanomedicine. 2016 Nov;12(8):2439-2448. doi: 10.1016/j.nano.2016.07.001. Epub 2016 Jul 16.

PMID:
27431054
11.

Transcutaneous immunotherapy of pollinosis using solid-in-oil nanodispersions loaded with T cell epitope peptides.

Kong Q, Kitaoka M, Wakabayashi R, Kamiya N, Goto M.

Int J Pharm. 2017 Aug 30;529(1-2):401-409. doi: 10.1016/j.ijpharm.2017.07.020. Epub 2017 Jul 10.

PMID:
28705615
12.

Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.

Kumar A, Li X, Sandoval MA, Rodriguez BL, Sloat BR, Cui Z.

Int J Nanomedicine. 2011;6:1253-64. doi: 10.2147/IJN.S20413. Epub 2011 Jun 21.

13.

Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.

Kim KS, Kim H, Park Y, Kong WH, Lee SW, Kwok SJ, Hahn SK, Yun SH.

Adv Funct Mater. 2016 Apr 19;26(15):2512-2522. Epub 2016 Feb 1.

14.

Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.

Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y.

Int J Pharm. 2013 Apr 15;447(1-2):22-30. doi: 10.1016/j.ijpharm.2013.02.006. Epub 2013 Feb 11.

PMID:
23410987
15.

Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.

Mitsui H, Okamoto T, Kanzaki M, Inozume T, Shibagaki N, Shimada S.

Br J Dermatol. 2010 Jan;162(1):29-41. doi: 10.1111/j.1365-2133.2009.09490.x. Epub 2009 Oct 26.

PMID:
19863514
16.

Induction of immunological tolerance by oral, but not intravenous and intraportal, administration of ovalbumin and the difference between young and old mice.

Wakabayashi A, Utsuyama M, Hosoda T, Sato K, Takahashi H, Hirokawa K.

J Nutr Health Aging. 2006 May-Jun;10(3):183-91.

PMID:
16622581
17.
18.

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, Vardaxis N, Plebanski M.

Mol Pharm. 2007 Jan-Feb;4(1):73-84.

PMID:
17274665
19.

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

Slütter B, Bal S, Keijzer C, Mallants R, Hagenaars N, Que I, Kaijzel E, van Eden W, Augustijns P, Löwik C, Bouwstra J, Broere F, Jiskoot W.

Vaccine. 2010 Aug 31;28(38):6282-91. doi: 10.1016/j.vaccine.2010.06.121. Epub 2010 Jul 16.

PMID:
20638455
20.

Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.

Jain A, Yan W, Miller KR, O'Carra R, Woodward JG, Mumper RJ.

Int J Pharm. 2010 Nov 30;401(1-2):87-92. doi: 10.1016/j.ijpharm.2010.09.003. Epub 2010 Sep 15.

Supplemental Content

Support Center